Medicines

Drug-shortage re-stress

A forward-dated medicine-supply stress across assumed manufacturer, wholesaler, care-site, and treatment-access links.

scenario onlyquasi historicalevidence required

Decision question

Which bounded supply intervention remains feasible when a medicine becomes constrained?

Context-only public reference; all topology and numeric parameters are explicit model assumptions.

Generated bounds

Lower0.066140

Central0.066140

Upper0.169978

Dimensionless weighted stress under declared assumptions—not a realized-loss estimate.

Artifact identity

Nodes / edges: 5 / 4
Snapshot: 2ae5aa23b7b3d922122ed2ef7cf25606a8bbb58e1bed7aa47f460a8d315d3c3e
Observability: not cost effective

Context—not numeric evidence

openFDA Drug Shortages API

This official/public page motivates the stress question. It does not provide the topology, weights, shock magnitude, intervention effects, or outcome labels.

Open U.S. Food and Drug Administration

Independent verification

Rebuild the complete evidence chain.

npm run cascadelens -- cases build drug-shortage-restress
npm run cascadelens -- verify content/cases/drug-shortage-restress/riskpack/

Download RiskPack